Translational Oncology

Translational Oncology期刊基本信息

Translational Oncology
  • 简称:TRANSL ONCOL
  • 大类:医学
  • 小类:肿瘤学
  • ISSN:1936-5233
  • IF值:3.138
  • 周期:Quarterly
  • 是否OA:No
  • 年文章数:116
  • 审稿速度:较慢,6-12周
  • 平均录用比例:较易
投稿咨询

官方网站:

投稿网址:

PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1936-5233%5BISSN%5D

Translational Oncology中文简介

转化肿瘤学发表新研究调查的结果,连接实验室和临床设置,包括风险评估,细胞和分子特征,预防,检测,诊断和治疗人类癌症的整体目标是改善肿瘤患者的临床护理。转化肿瘤学将发表新的治疗干预措施的实验室研究,以及评估癌症新治疗模式的临床试验。同行评审的稿件类型包括原始报告、评审和社论。

Translational Oncology英文简介

Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.

国际期刊推选 论文翻润预审发表!

选择丰富服务快速通过率高一键快速领取私人专属发表方案!

* 请认真填写需求信息,学术顾问24小时内与您取得联系。